There is increasing interest in clinical guidelines within the United Kingdom. With this interest has come an increasing awareness of the methodological issues involved in guideline development, although reports are limited. ' Woolf described three main methods of guideline development: informal consensus, formal consensus, and evidence linked. 2 In guidelines developed through informal consensus, the method used most often in the United Kingdom, the guideline panel has poorly defined, often implicit, criteria for decision making. Development by formal consensus, used by many consensus development conferences and Delphi groups, provides "greater structure to the analytical process" but still fails to provide "an explicit linkage between recommendations and quality of evidence."2 Guideline development linked to evidence requires the explicit link between recommendations and the quality of the supporting evidence.' ' This allows the user to make an informed choice about whether or not to comply with recommendations.
Guidelines are valid if "when followed they lead to the health gains and costs predicted for them." 5 We have previously argued that linking guidelines to evidence is one of three developmental prerequisites necessary to maximise guideline validity,6 the other two being systematic review of the evidence and guideline development occurring within an appropriately multidisciplinary group. These methods are unlikely to be used at a local (as opposed to a regional or national) level as necessary skills are unlikely to be available. Local groups should concentrate on identifying valid regional or national guidelines which they can then adapt to their local needs.7 Unfortunately such valid guidelines are few and descriptions of their development in the United Kingdom are non-existent.
This article describes the development of explicit, evidence based guidelines for the primary care management of asthma in adults and for stable angina,8-12 two chronic conditions, predominantly managed in primary care and important because of their associated morbidity and mortality. 13 We present our experiences and the methodological issues considered during guideline development, both for those who are involved in this process and for those who wish to know more about the practicalities.
Setting up the guideline development project To develop guidelines successfully it was necessary to convene four groups: a project team; a project management group; and two guideline development groups. The project team was composed of the principle investigator, a junior research associate employed to work full time on the project, a cardiologist, and a chest physician. The role of the project team was to undertake the day to day running of the project; this involved the identification and interpretation of relevant evidence, the convening and running of the guideline development groups, and the production of the resulting guidelines. The project management group was composed of specialists in guideline methodology and a health information expert; their role was to provide technical advice on a formal or informal basis throughout the project. The guideline development groups were to produce guideline recommendations in the light of the evidence.
Guideline development groups MEMBERSHIP AND ROLES WITHIN THE GROUPS
The composition of a guideline development group depends on the roles required within the group and the disciplines or backgrounds of the group members who were stakeholders in the processes covered by the guideline. All the parties whose activities would be covered by the guideline or who had other legitimate reasons for having an input into the process have to be identified. This is important to ensure adequate discussion of the evidence (or its absence) when developing the recommendations in the guideline.6 14 Given that both guidelines were for use in primary care the stakeholders involved (and their eventual numbers in each group) were: general practitioners (five), practice nurses (two), representatives of patients (one), secondary care physicians (one), public health physicians (one), and health economists (one).
From a theoretical basis we identified the roles required within the guideline development groups as those of group member, group leader, specialist clinician, technical assistant, and administrative assistant. All recruited people needed to have two specific characteristics: interest in the project and a positive attitude towards guidelines. As the subjects of the guidelines were broad clinical conditions, a single wide ranging search for each condition was used, rather than a series of focused searches aimed at specific issues. However, in the light of the results of the two main searches a few specific searches were conducted. All searches were limited to studies of human adults written in English. For both areas we conducted medical subject headings (MeSH) and free text searches on the terms meta-analysis, randomised controlled trial, reviews, cohort studies, and case-control studies. For asthma we also sought the terms asthma, peak expiratory flow rate, lung diseases obstructive, forced expiratory volume, and paroxysmal dyspnoea; and for stable angina the terms coronary disease, angina pectoris. Additional specific MEDLINE searches were carried out on the following terms: decision making, theophylline, terbutaline, antihistamine, isosorbide, myocardial infarction, secondary prevention, and buccal. The BIDS electronic database2' was also searched (with the search terms: asthma plus management and angina plus management). References were also identified from two other sources. Firstly, if there was no recent evidence in a clinically important area the specialist clinician was asked to identify, from his personal knowledge, key articles published before 1985. Secondly, the reference lists of non-systematic reviews were checked. We did not attempt to access the "grey literature"; nor did we identify letters in response to original articles.
Initial sifting
The identified papers were first sifted on the basis of title only by the principle investigator, a medically qualified health services researcher; they were then sifted on the basis of title and abstract by the specialist clinician. Both were working to agreed criteria of clinical relevance; as the initial sift was on title alone if there was any doubt about an article's relevance it was retained for fuller assessment. However, articles about topics irrelevant to the guidelines, such as anaesthetics, were readily identified and removed.
Methodological assessment
The collected papers were then assessed against a set of methodological criteria several of which were pass or fail.8 9 As an example one such criterion was that any randomised controlled trial with a group size of less than 20 would be excluded. This criterion was used because we thought that it was reasonable to consider only studies of a minimum size given that we did not propose to undertake a formal meta-analysis. When Kleijnen et al looked at size criteria in a review of clinical trials of homoeopathy they argued that "In trials with limited numbers of participants one cannot be confident that randomisation will equally divide known and unknown confounders over the experimental and control groups. As well, publication bias may be less likely for experiments with large numbers of participants."22 As a result of this they did not score trials with group sizes less than 25. In a similar review of physiotherapy the same research group did not score trials with group sizes of 50 or less.23 Also, the analysis of such studies would have required statistical correction (Yates's correction or the use of small sample size tests such as Fisher's exact test) and would need to be treated with caution if generalizations were to be made from them. Table 1 shows the number of papers remaining after the various stages of the shifting process.
Summarising evidence Papers which passed the methodological sift were then read and summarised by the specialist; several discrete areas were reviewed by other invited group members. They were supported in this by members of the project team. The reviewer, with members of the project team, abstracted the evidence from the papers. The evidence was graded according to the study design with a grading system adapted from the Canadian task force classification (table 2).24 The evidence was summarised with qualitative methods. Quantitative (meta-analysis) techniques were not used as we were dealing with studies other than randomised controlled trials.
Method of constructing guidelines GROUP MEETINGS
The groups chose to conduct their work over a series of half day meetings, rejecting the option of committing larger blocks of time on fewer occasions. Both groups met on nine occasions. The first half of the first meeting was devoted solely to introductions and discussion of the task. This second topic recurred on several occasions, most often in the early meetings, although aspects of the definition of the group task occurred all the way through. Having agreed on the task the groups were presented with evidence from which they were to make recommendations. At the early meetings the groups discussed the papers and their interpretation which gave them a clear idea of the review process. As the reviewing process developed they were presented with draft recommendations linked to statements of the evidence and to blocks of summarised papers. The recommendations and the statements were then discussed and suggested changes were edited into the developing guideline by the project team between meetings. In both groups the decision making process was informal consensus; no formal strategies were used.
DERIVING RECOMMENDATIONS
Recommendations were graded A to C ( are demarcated ... and a distinction made between evidence of ineffectiveness ... and the absence of evidence for effectiveness., '7 The two groups chose different strategies to achieve this. The asthma group decided that in the absence of evidence their first recourse would be to a current national consensus guideline.26 If these recommendations were appropriate they would be used. If they had been superseded, or did not provide a relevant recommendation, then the group would reach its own consensus view. In the absence of a widely recognised national guideline the angina group decided that they would make recommendations based on their experience and reach a consensus view on what the recommendation should say. Both groups agreed that if it were not possible to reach a consensus then the relevant area would be explicitly identified as one where the group could not agree. The areas without evidence generated more discussion and disagreement within the group than any of the areas in which there was evidence.
Involvement of patients in guideline development Although we invited two patients to be group members and they attended meetings regularly they were often non-participating observers of technical discussion to which they could offer no input. Although the input of patients into the process of guideline development is important, this may be better gathered outside the guideline development group, with techniques such as focus groups, rather than having a single patient as a frequently nonparticipating group member. This is an area where further methodological research is clearly required.
External review of the guideline We identified the need for three groups of reviewers: guideline experts to review the methods; content area experts to review the interpretation, logic, and clarity; and potential users to appraise the clinical applicability and usefulness of the guidelines. The purpose of the review was to identify errors in the areas that the reviewers were asked to cover; it was not to undertake a further round of consensus interpretation of the contents of the guideline. In choosing the number of reviewers there was a trade off between the breadth of review sought and the subsequent task of dealing with detailed comments; we used up to nine reviewers on each guideline.
Reviewers' comments were amalgamated and then ordered by page of the guidelines so that they could be easily identified by the project team and the guideline development groups to whom they were sent. All comments and responses were considered and the errors identified were amended in the final draft. An example of an issue raised by reviewers was the concern of the specialists who reviewed the angina guideline about a recommendation suggesting that general practitioners use verapamil with a blockers (the systematic review had produced several randomised controlled trials that had shown the combination to be effective). The reviewers' comments combined with the cautions within the British National Formulary27 led to the recommendation being withdrawn. The guidelines were sent to reviewers as both an advanced draft of the complete guideline and as a shorter, four page, "quick reference guide for clinicians." The potential users of the guidelines (all general practitioners) expressed concern about the usefulness of the quick reference guide on the basis that it was too short to have the legitimacy of a full evidence based document but was too long to be readily usable. In the light of these comments the quick reference guide was dropped and the reviewer's suggested single sheet summary produced instead.
Timetabling
In the original proposal to the funding body the development of the guidelines was scheduled to take 12 months; in retrospect this was not long enough. The first three months were taken up with the initial organisation of the systematic review, the identification of potential group members, and the necessary time leading up to the first meetings. By the end of 12 months the nine monthly meetings of each group were complete and the draft versions of the guidelines were ready to go out to reviewers. Although reviewers were identified in advance the review process and the subsequent editing and production of the guidelines took a further six months.
There are certain fixed periods in the process that could not be shortened. For example, once the decision had been taken to develop the guidelines over nine half day meetings, the process inevitably took nine months because clinicians found it impossible to meet more often. Also, it would have been difficult to have completed the evidence review process in time for more frequent meetings. Therefore, with three months required to set up the project, the phase that was not accurately predicted was that of external review and the subsequent guideline production. Given the other pressures on the reviewers we were very fortunate that they were able to comment within a four week period. The collation of their comments and the responses to them required a further four weeks and these then had to be sent out to the groups for their responses with a further four week turnaround. After further collation over the subsequent two weeks the guidelines were only then ready for the final proof reading and the production phase.
Discussion
We have presented the experiences from, and issues raised by, developing two evidence based guidelines. Guideline development required a range of skills. Identifying and assimilating the evidence required the skills of systematic reviewing to identify relevant papers and then the skills of an experienced and critical clinician to summarise their clinical relevance. The evidence was fed to large 
